Zantac 150 and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zantac 150 (ranitidine hydrochloride) and Prograf (tacrolimus). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Zantac 150 and Prograf. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Zantac 150?

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,519 Zantac 150 users. Check the latest studies of Zantac 150.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.



On Jul, 16, 2026

44 people who take Zantac 150 and Prograf together, and have interactions are studied.

Zantac 150 and Prograf drug interactions.

What are the common drug interactions of Zantac 150 and Prograf, by gender? *:

female:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Blood creatinine increased
  4. Blood pressure decreased
  5. Blood pressure increased
  6. Blood urea increased
  7. Bone marrow failure
  8. Culture urine positive
  9. Escherichia infection (bacterial infection by escherichia coli)
  10. Escherichia urinary tract infection (urinary tract infection by escherichia coli)

male:

  1. Chronic kidney disease
  2. Blood albumin decreased
  3. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  4. Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
  5. Diarrhoea
  6. Infection
  7. Pyrexia (fever)
  8. Drug hypersensitivity
  9. Pseudarthrosis (bones that do not heal after fracture)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Zantac 150 and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Vomiting
  2. Blood pressure decreased
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Acute respiratory distress syndrome
  7. Epistaxis (bleed from the nose)
  8. Haematemesis (vomiting of blood)
  9. Nausea (feeling of having an urge to vomit)
  10. Pulmonary haemorrhage (acute bleeding from the lung)

10-19:

  1. Apnoea (suspension of external breathing)
  2. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  3. Headache (pain in head)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  6. Carotid artery stenosis (narrowing of carotid artery)
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Haemorrhage intracranial (bleeding within the skull)
  9. Heart transplant rejection
  10. Blood creatinine increased

20-29:

  1. Kidney transplant rejection

30-39:

  1. Blood albumin decreased
  2. Blood lactate dehydrogenase increased
  3. Pneumonia
  4. Osteomyelitis (infection of bone)
  5. Sternal fracture
  6. Transplant rejection (a transplant material is not worked)
  7. Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
  8. Pyrexia (fever)
  9. Drug hypersensitivity
  10. Pseudarthrosis (bones that do not heal after fracture)

40-49:

  1. Renal haematoma (blood collection in kidney)
  2. Urinary retention (the inability to completely or partially empty the bladder)

50-59:

  1. Arthralgia (joint pain)
  2. Haematocrit decreased
  3. Kidney transplant rejection
  4. Myalgia (muscle pain)
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  6. Renal graft loss

60+:

  1. Chronic kidney disease
  2. Infection
  3. Intestinal obstruction
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Pleural effusion (water on the lungs)
  6. Renal impairment (severely reduced kidney function)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Right ventricular failure (right half of the heart fails to work)
  9. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 9.09%
  2. High Blood Cholesterol: 4 people, 9.09%
  3. Diabetes: 4 people, 9.09%
  4. Renal Disorder (kidney disease): 3 people, 6.82%
  5. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 6.82%
  6. Febrile Neutropenia (fever with reduced white blood cells): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac 150 and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zantac 150 and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac 150:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zantac 150 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and tacrolimus (the active ingredients of Zantac 150 and Prograf, respectively), and Zantac 150 and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: